New treatment target found for CDKL5 deficiency disorder

Scientists at the Francis Crick Institute have found a new treatment target for CDKL5 deficiency disorder (CDD), one of the most common types of genetic epilepsy.

SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results

A former Pfizer statistician on Thursday was charged by U.S. authorities with insider trading for acting on advance information about trial results for the Paxlovid

June 29, 2023

MedPod Today: RFK Jr.’s Ailments; Tenpenny Gets License Back; Shady Stem Cell Shots

The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody! Welcome to MedPod Today, the podcast series where MedPage Today reporters share

May 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

New treatment target found for CDKL5 deficiency disorder

SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results

MedPod Today: RFK Jr.’s Ailments; Tenpenny Gets License Back; Shady Stem Cell Shots

Adverse childhood experiences may increase the odds of muscle dysmorphia in young people

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe